Elanco Animal Health Inc (ELAN) Stock Price, Quote & News

Company Profile

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. It offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under the Crede...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 877 352 6261

Website: www.elanco.com

Address:

2500 Innovation Way, Greenfield, United States

LtFrankDrebin Oct. 26 at 8:30 PM

$ELAN Elanco received an emergency-use authorization for it's screwworm treatment, the first time this authorization has happened for an animal drug. This is because this is much bigger than treating a pet worm, since the FDA said this parasite poses a threat to livestock and food security near the US-Mexico border, as reported by the WSJ. https://www.wsj.com/health/healthcare/elanco-animal-health-obtains-fda-authorization-for-screwworm-treatment-c5566ad7

0 · Reply

AStrokeOfLuck Oct. 24 at 9:42 PM

$ELAN

0 · Reply

SuperGreenToday Oct. 22 at 11:34 AM

$ELAN Share Price: $21.62 Contract Selected: Apr 17, 2026 $20 Calls Buy Zone: $2.52 – $3.12 Target Zone: $4.46 – $5.45 Potential Upside: 67% ROI Time to Expiration: 176 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

JarvisFlow Oct. 20 at 10:20 PM

UBS has adjusted their stance on Elanco Animal Health ( $ELAN ), setting the rating to Buy with a target price of 19 → 25.

0 · Reply

LtFrankDrebin Oct. 20 at 12:12 PM

$ELAN There aren't many stocks out there with this good of a 6 month chart. A gradual rise up with upgrade after upgrade along the way.

0 · Reply

StealthTickerg Oct. 17 at 4:01 PM

$ELAN Gross margin near 64 percent on 894k revenue in 2024 says the unit model has teeth, push volumes through EU partnerships and fixed costs dilute fast, at 5M to 15M sales even a 6x to 10x P S resets EV hard

0 · Reply

ivanhoff Oct. 17 at 3:01 PM

Only four stocks on the new 52-week relative strength high list so far this morning - $ELAN $MLYS $ASX $CLS

0 · Reply

MoneyGroupLLC Oct. 17 at 2:45 PM

Enter: $ELAN NOV 21 2025 $21 CALLS Buy in Price: $1.10 - $1.45 Take Profit: $2.12 Stop Bleeding: $0.97 ROI Potential: 93% Exit Within: 2 Weeks https://moneygroup.us/alerts

0 · Reply

LtFrankDrebin Oct. 15 at 12:10 PM

$ELAN Zenrelia is their new pet allergy drug, and it's becoming increasingly popular in vet offices across the country. It's considerably cheaper than the popular pet allergy drug Apoquel, and many are finding it more effective. With dog and cat allergies becoming more and more of an issue, many vets across the country are prescribing this drug instead of Apoquel to treat them.

0 · Reply

Gomenated Oct. 13 at 1:48 PM

$NVNI not advice, the big algos are at risk of lending shares and hedging downside bets. Until the Vix and Spy cool off, im going to wait it out. Everything is at the verge of another pop or a massive drop. I sold $CHEWY $OCUGEN $ELAN $NVNI $COSM $ANGX will wait it out and see what I can do. All for gains. But will decide what to do with capital later. Liquidated 30k down to about 5k.

1 · Reply

Elanco Announces Expansion of Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) and Credelio™ (lotilaner) Labels, Offering Protection Against Lyme Disease and an Emerging Tick Species

Oct 24, 2025, 6:10 PM EDT - 2 days ago

Elanco gets US FDA emergency nod for dog drug as threat of flesh-eating parasite looms

Oct 24, 2025, 5:33 PM EDT - 2 days ago

Elanco Animal Health Obtains FDA Authorization for Screwworm Treatment

Oct 24, 2025, 4:55 PM EDT - 3 days ago

Elanco's Credelio™ (lotilaner) Receives First Ever FDA Emergency Use Authorization (EUA) against New World Screwworm (NWS) in Dogs

Oct 16, 2025, 4:32 PM EDT - 11 days ago

Elanco to Host Investor Day on December 9

Oct 1, 2025, 8:00 AM EDT - 26 days ago

Elanco Confirms Date and Conference Call for Third Quarter 2025 Financial Results Announcement

Sep 23, 2025, 6:27 AM EDT - 4 weeks ago

Elanco Announces FDA Approves Improved Zenrelia™ (ilunocitinib tablets) Label, Removing Vaccine-Induced Disease Language

Sep 9, 2025, 1:11 PM EDT - 6 weeks ago

Elanco Animal Health Incorporated (ELAN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Sep 8, 2025, 6:27 AM EDT - 7 weeks ago

Elanco Innovation Builds Momentum, Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Reaches Blockbuster Status

Aug 27, 2025, 8:00 AM EDT - 2 months ago

Splenda® Joins Elanco and HATCH to Support 'Nutrition Secure Indianapolis' to Strengthen Family Health Through Nutrition and Education

Aug 26, 2025, 6:15 PM EDT - 2 months ago

Elanco Animal Health Set to Join S&P MidCap 400; Sarepta Therapeutics to Join S&P SmallCap 600

BBT BRKL

Aug 26, 2025, 8:00 AM EDT - 2 months ago

Elanco to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference

Aug 7, 2025, 7:52 PM EDT - 2 months ago

Elanco Animal Health Incorporated (ELAN) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 5:33 PM EDT - 2 months ago

Elanco Animal Health Q2: Rising Innovation Revenue, Initiate At Buy

Aug 7, 2025, 12:23 PM EDT - 2 months ago

Elanco Animal Health Soars Past 52-Week High On Strong Sales, Raised Annual Outlook

Aug 7, 2025, 6:27 AM EDT - 2 months ago

Elanco Animal Health Reports Second Quarter 2025 Results

Jul 24, 2025, 5:42 PM EDT - 3 months ago

Elanco Secures Approval of Zenrelia™ (ilunocitinib) in the European Union (EU), Launching Innovative Canine Dermatology Treatment for Itchy Dogs

Jul 10, 2025, 8:00 AM EDT - 3 months ago

Elanco Confirms Date and Conference Call for Second Quarter 2025 Financial Results Announcement

Jul 9, 2025, 10:01 AM EDT - 3 months ago

Elanco's dog flu vaccine gets USDA nod

Jul 9, 2025, 8:27 AM EDT - 3 months ago

Elanco Receives USDA Approval for TruCan™ Ultra CIV H3N2/H3N8 (Canine Influenza Vaccine) Bringing to Market a High Standard of Respiratory Protection

Jul 2, 2025, 7:09 PM EDT - 4 months ago

Neurizon Enters into Global License with Elanco to Accelerate Commercialisation of NUZ-001

Jun 26, 2025, 2:38 PM EDT - 4 months ago

Elanco Animal Health Gets Its Bite Back, Pipeline Efforts Earn Praise

Jun 26, 2025, 1:00 PM EDT - 4 months ago

Elanco Releases 2024 Impact Report and Introduces New Framework

Jun 12, 2025, 4:17 PM EDT - 4 months ago

Elanco Receives Positive Opinion on Zenrelia (ilunocitinib) from EU's Committee for Veterinary Medicinal Products (CVMP)

Jun 5, 2025, 7:45 AM EDT - 5 months ago

Elanco Releases New Report Highlighting the Significance of America's Itchy Dogs and the Need for Itch Relief

May 28, 2025, 7:25 AM EDT - 5 months ago

Elanco Appoints Robert (Bob) VanHimbergen as Chief Financial Officer

May 16, 2025, 8:00 AM EDT - 5 months ago

Elanco to Participate in the Upcoming Investor Conferences

May 12, 2025, 4:26 AM EDT - 6 months ago

Elanco: Deleveraging Takes Time

May 7, 2025, 12:52 PM EDT - 6 months ago

Elanco Animal Health Incorporated (ELAN) Q1 2025 Earnings Call Transcript

May 7, 2025, 11:03 AM EDT - 6 months ago

Animal Health Elanco Chirps A Solid Quarter Tempered By Soft Q2 EPS Guide

May 7, 2025, 6:27 AM EDT - 6 months ago

Elanco Animal Health Reports First Quarter 2025 Results

May 6, 2025, 10:00 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Elanco Animal Health Incorporated (ELAN) And Encourages Shareholders to Connect

May 5, 2025, 4:40 PM EDT - 6 months ago

Elanco Animal Health Sells Xdemvy Royalties To Blackstone in $295 Million Deal

May 5, 2025, 6:27 AM EDT - 6 months ago

Elanco Sells Royalty and Milestone Rights for Lotilaner in Human Health to Blackstone; Accelerates Debt Paydown

TARS

May 4, 2025, 10:00 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Elanco Animal Health Incorporated (ELAN) And Encourages Shareholders to Reach Out

May 1, 2025, 10:00 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elanco Animal Health Incorporated (ELAN) and Encourages Shareholders to Learn More About the Investigation

Apr 29, 2025, 10:00 AM EDT - 6 months ago

Elanco Animal Health Incorporated (ELAN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Apr 24, 2025, 10:00 AM EDT - 6 months ago

Elanco Animal Health Incorporated (ELAN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Apr 23, 2025, 1:16 PM EDT - 6 months ago

Trade Tracker: Sarat Sethi buys Zoetis and sells Elanco

ZTS

Apr 22, 2025, 10:00 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Elanco Animal Health Incorporated (ELAN) And Encourages Investors to Connect

Apr 22, 2025, 8:27 AM EDT - 6 months ago

Elanco's Breakthrough Treatment for Deadly Canine Parvovirus Has Saved Thousands of Puppies, Reaffirms Commitment to Increasing the Availability of Canine Parvovirus Monoclonal Antibody for Second Annual National Parvo Awareness Day

Apr 20, 2025, 10:00 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Elanco Animal Health Incorporated (ELAN) Stockholders to Inquire about Securities Investigation

Apr 17, 2025, 10:00 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elanco Animal Health Incorporated (ELAN) and Encourages Investors to Learn More About the Investigation

Apr 15, 2025, 10:00 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Elanco Animal Health Incorporated (ELAN) And Encourages Stockholders to Connect

Apr 13, 2025, 10:00 AM EDT - 7 months ago

Elanco Animal Health Incorporated (ELAN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Apr 10, 2025, 10:00 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elanco Animal Health Incorporated (ELAN) and Encourages Stockholders to Learn More About the Investigation

Apr 10, 2025, 8:00 AM EDT - 7 months ago

Elanco Confirms Date and Conference Call for First Quarter 2025 Financial Results Announcement

Apr 8, 2025, 10:00 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Elanco Animal Health Incorporated (ELAN) Investors to Inquire about Securities Investigation

Apr 6, 2025, 10:00 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Elanco Animal Health Incorporated (ELAN) And Encourages Investors to Reach Out

LtFrankDrebin Oct. 26 at 8:30 PM

0 · Reply

AStrokeOfLuck Oct. 24 at 9:42 PM

$ELAN

0 · Reply

SuperGreenToday Oct. 22 at 11:34 AM

0 · Reply

JarvisFlow Oct. 20 at 10:20 PM

UBS has adjusted their stance on Elanco Animal Health ( $ELAN ), setting the rating to Buy with a target price of 19 → 25.

0 · Reply

LtFrankDrebin Oct. 20 at 12:12 PM

$ELAN There aren't many stocks out there with this good of a 6 month chart. A gradual rise up with upgrade after upgrade along the way.

0 · Reply

StealthTickerg Oct. 17 at 4:01 PM

0 · Reply

ivanhoff Oct. 17 at 3:01 PM

Only four stocks on the new 52-week relative strength high list so far this morning - $ELAN $MLYS $ASX $CLS

0 · Reply

MoneyGroupLLC Oct. 17 at 2:45 PM

Enter: $ELAN NOV 21 2025 $21 CALLS Buy in Price: $1.10 - $1.45 Take Profit: $2.12 Stop Bleeding: $0.97 ROI Potential: 93% Exit Within: 2 Weeks https://moneygroup.us/alerts

0 · Reply

LtFrankDrebin Oct. 15 at 12:10 PM

0 · Reply

Gomenated Oct. 13 at 1:48 PM

1 · Reply

Gomenated Oct. 10 at 3:58 PM

$NVNI $COSM $ELAN $ANGX sold most of my positions to offset taxes this year. Im not paying gain on unrealized profits that I took to soon. Regained my capital for other things for now. Ill redistribute my small wealth when the time is right. What a beautiful year, I broke even on the year sadly due to bad options trading and by choice due to taking my profits and putting back in nvni for a loss. but either way! went on a 30k run over 3 months after being down 10k! What a win in my books. Average of 300% on all my positions!! Wooh!!

0 · Reply

Gomenated Oct. 7 at 11:09 AM

$NVNI still here $COSM still being lame. $OCGN loving it. $ELAN price target increase. Im now up 900% on my options. Guess im a shitty trader too cause I cant always prevent being blindsided ^-^ Just looked, I have almost 100% on all stocks on my portfolio in less than a year. Some a few months. And some well over 100% just averaged up.. or bought back in^-^ haha tax offset of profits , for huge gains and government gets there part. Either way I win.

0 · Reply

theflynews Oct. 7 at 9:03 AM

Elanco just upgraded at JPMorgan, here's why - $ELAN - https://thefly.com/permalinks/entry.php/ELANid4208601?1759827798C38

0 · Reply

MoneyGroupLLC Oct. 4 at 2:33 AM

Enter: $ELAN NOV 21 2025 $21 CALLS Buy in Price: $1.40 - $1.40 Take Profit: $2.66 Stop Bleeding: $1.23 ROI Potential: 90% Exit Within: 144 Minutes https://moneygroup.us/alerts

0 · Reply

SweepCastApp Oct. 3 at 8:45 AM

$ELAN: Unusual Options Activity Alerted CALL flow observed 302x contracts at Strike price of $24 Exp on 04/17/2026 with Premium of $45K and showing BULLISH Sentiment

0 · Reply

Gomenated Sep. 30 at 11:29 AM

$NVNI havent shared my average on my portfolio for my remembering in a bit. Nvni- up 300+%, centered with average of 1.40 ++Average/current price $OCUGEN 1.01 / now 1.52 I have 20+contracts 2026 and 2027 at .50 Average. 65 $CHEWY 32.40/ now 39.78 $COSM .76 after averaging up/ now1.04 Watching close. $ELAN 11.06 averaged up/ now 19.50 3 $15 call 1.05 Average /6.55 now #angel new play. Entered Too early, averaged down to 5.56/ 5.59 now. $ZOMDF , it went otc. But Average of .1157/ .08 but recovered from .03

1 · Reply

SweepCastApp Sep. 27 at 2:59 PM

$ELAN: SWEEP PUT flow in tape 88 @ 2.90 Strike 21 Exp 04/17/2026 Premium $25.5K Sentiment BULLISH

0 · Reply

MoneyGroupLLC Sep. 26 at 3:54 AM

Enter: $ELAN OCT 17 2025 $19 CALLS Buy in Price: $0.45 - $0.75 Take Profit: $0.95 Stop Bleeding: $0.40 ROI Potential: 110% Exit Within: 152 Minutes https://moneygroup.us/alerts

0 · Reply

MoneyGroupLLC Sep. 21 at 2:07 PM

Enter: $ELAN OCT 17 2025 $20 CALLS Buy in Price: $0.33 - $0.45 Take Profit: $0.67 Stop Bleeding: $0.29 ROI Potential: 102% Exit Within: 254 Minutes https://moneygroup.us/alerts

0 · Reply

MaurineSweeney457 Sep. 21 at 10:47 AM

$ELAN Pharmaceutical growth. Breaking above resistance. Volume expansion noted. Relative strength.

0 · Reply

MoneyGroupLLC Sep. 19 at 1:45 PM

Enter: $ELAN OCT 17 2025 $19 CALLS Buy in Price: $0.55 - $0.70 Take Profit: $1.28 Stop Bleeding: $0.62 ROI Potential: 83% Exit Within: 102 Minutes https://moneygroup.us/alerts

0 · Reply

MyChicago Sep. 18 at 3:12 PM

$ZOMDF 4 new patents issued today. Zomedica now has a portfolio of 228 patents and 153 trademarks globally. $WOOF $ZTS $IDXX $ELAN

1 · Reply

Market Cap	10.95B
Revenue (ttm)	4.44B
Net Income (ttm)	338.00M
EPS (ttm)	N/A
PE Ratio	24.19
Forward PE	24.43
Profit Margin	7.61%
Debt to Equity Ratio	0.62

Volume	3,919,521
Avg Vol	7,260,288
Day's Range	N/A - N/A
Shares Out	496.81M
Stochastic %K	92%
Beta	1.65
Analysts	Strong Sell
Price Target	$22.11